Recent News

• 06.12.2025 - Lynn Tetrault, J.D.
• 06.12.2025 - Lynn Tetrault, J.D.
• 06.04.2025 - June 4, 2025 3:10 PM EDT - June 4, 2025 3:40 PM EDT : Jefferies Global Healthcare Conference
• 06.04.2025 - June 4, 2025 3:10 PM EDT - June 4, 2025 3:40 PM EDT : Jefferies Global Healthcare Conference
• 05.29.2025 - Alumis to Present at the Jefferies Global Healthcare Investor Conference
• 05.29.2025 - Alumis to Present at the Jefferies Global Healthcare Investor Conference
• 05.29.2025 - Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of Moderate-to-Severe Plaque Psoriasis
• 05.29.2025 - Alumis Completes Enrollment of Pivotal Phase 3 ONWARD Clinical Program of Lead Candidate ESK-001, a Highly Selective, Next-Generation Oral TYK2 Inhibitor for the Treatment of Moderate-to-Severe Plaque Psoriasis
• 05.21.2025 - Alumis Completes Merger with ACELYRIN
• 05.21.2025 - Alumis Completes Merger with ACELYRIN

Recent Filings

• 06.10.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 06.10.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 05.23.2025 - 3 Initial statement of beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.23.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 05.21.2025 - 8-K Current report
• 05.21.2025 - EX-99.1 EX-99.1